Search Results
Found 1 results
510(k) Data Aggregation
(91 days)
BNZG reagent, when used in conjunction with SYNCHRON® System(s) and SYNCHRON® Systems Drugs of Abuse Testing (DAT) Urine Calibrators, is intended for the qualitative determination of Benzodiazepine (BNZG) in human urine at a cutoff value of 200 ng/mL (oxazepam).
The BNZG assay provides a rapid screening procedure for determining the presence of the analyte in urine. This test provides only a preliminary analytical result, a positive result by these assays should be confirmed by another generally accepted non-immunological method such as thin layer chromatography (TLC), gas chromatography (GC), or gas chromatography/mass spectrometry (GC/MS). GC/MS is the preferred confirmatory method.
Here's an analysis of the acceptance criteria and supporting study for the SYNCHRON® Systems BNZG Reagent, based on the provided text:
1. Table of Acceptance Criteria and Reported Device Performance
The document doesn't explicitly state 'acceptance criteria' in a formal table with predefined targets. However, the study aims to demonstrate substantial equivalence to a predicate device, and the concordance summary provides the key performance metrics. Based on common practice for this type of device, acceptable performance would typically involve high sensitivity, specificity, and overall agreement with a confirmatory method, as well as good imprecision.
Here's a table based on the provided results, with implied acceptance based on the successful clearance of the device:
| Metric | Acceptance Criteria (Implied) | Reported Device Performance (SYNCHRON® Systems BNZG Reagent) |
|---|---|---|
| Concordance Study | ||
| Sensitivity | High agreement with GC/MS (e.g., >90%) | 98% (for both SYNCHRON CX and LX systems) |
| Specificity | High agreement with GC/MS (e.g., >80%) | 84% (for both SYNCHRON CX and LX systems) |
| Overall Agreement | High agreement with GC/MS (e.g., >90%) | 92% (for both SYNCHRON CX and LX systems) |
| Imprecision Study | (Representative values shown) | |
| Within-Run %CV | Low variability (e.g., < 2%) | 0.5% - 1.0% |
| Total %CV | Low variability (e.g., < 2%) | 0.7% - 1.0% |
2. Sample Size Used for the Test Set and Data Provenance
- Sample Size: 158 urine samples were used for the concordance study (103 positive, 55 negative).
- Data Provenance: The document does not explicitly state the country of origin or if the data was retrospective or prospective. It only presents the summary of "Performance Data."
3. Number of Experts Used to Establish the Ground Truth for the Test Set and Qualifications of Those Experts
- Number of Experts: Not applicable. The ground truth was established by a laboratory method (GC/MS), not by human expert opinion.
- Qualifications of Experts: Not applicable.
4. Adjudication Method for the Test Set
- Adjudication Method: Not applicable. There was no need for adjudication as the ground truth was established by a single, preferred confirmatory method (GC/MS).
5. If a Multi-Reader Multi-Case (MRMC) Comparative Effectiveness Study was Done, If So, What was the Effect Size of How Much Human Readers Improve with AI vs without AI Assistance
- No, an MRMC comparative effectiveness study was not done. This device is a diagnostic reagent, not an AI-powered image analysis tool or a system designed for human interpretation. Its performance is measured directly against a reference method.
6. If a Standalone (i.e. algorithm only without human-in-the loop performance) was Done
- Yes, a standalone study was done. The performance data (sensitivity, specificity, overall agreement, imprecision) presented for the SYNCHRON® Systems BNZG Reagent are based solely on the device's analytical capabilities without human-in-the-loop performance influencing the primary measurements. The output is a qualitative determination (positive/negative), which is then compared to the GC/MS result directly.
7. The Type of Ground Truth Used
- Ground Truth Type: Confirmatory laboratory method, specifically Gas Chromatography/Mass Spectrometry (GC/MS). The document explicitly states, "GC/MS is the preferred confirmatory method."
8. The Sample Size for the Training Set
- Not reported. The document focuses on the performance data of the reagent and does not provide information about a "training set," which is typically associated with machine learning or AI models. This is a traditional chemical assay, not an AI-driven device.
9. How the Ground Truth for the Training Set Was Established
- Not applicable. As no training set is mentioned or implied for this type of chemical reagent, the method for establishing its ground truth is not relevant here. The 'training' of such a device is typically through chemical formulation and optimization, not data-driven machine learning.
Ask a specific question about this device
Page 1 of 1